Breeze Meds vs Gala: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Breeze Meds beats Gala overall, scoring 7.3/10 vs 7/10. Gala is more affordable at $149/mo vs $199/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Gala for users who want low-cost compounded tirzepatide and a built-i.
A side-by-side comparison of Breeze Meds and Gala covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#30 of 42Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsGala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit Gala| Feature | Breeze Meds | Gala |
|---|---|---|
| Our Score | 7.3/10 | 7/10 |
| Starting Price | $199/mo | $149/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging |
| Ranking | #30 | #40 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Our Verdict
Breeze Meds edges out Gala with a score of 7.3/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Breeze Meds's $199/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging.